U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. 2017 PDA/FDA Biosimilars Conference, June 26-27, 2017
  1. News & Events for Human Drugs

2017 PDA/FDA Biosimilars Conference, June 26-27, 2017

Location:

Hyatt Regency Bethesda
1 Bethesda Metro Center
Bethesda, MD 20814
https://bethesda.regency.hyatt.com/en/hotel/home.html disclaimer icon

Background:

The FDA and PDA are co-sponsoring a conference to identify best practices for global development and approval for biosimilars, including:

  • Risk-based approaches to setting product specifications for quality attributes.
  • Practical solutions for establishing suitable control strategies over the biosimilar product lifecycle.
  • Approaches for global post-marketing change control.
  • Expectations for demonstrating analytical similarity.

Goals and Objectives:

  • Provide a forum for open discussion between industry, academia, regulatory agencies, and other stakeholders.
  • Seek feedback on best practices for risk-based approaches to setting product specifications for tier 1 and 2 quality attributes.
  • Map out priorities for control strategies over the biosimilar product lifecycle.
  • Accelerate the development and review of biosimilars.
  • Ensure that leading experts in biological products and biosimilars have an opportunity to discuss current Agency expectations for approval for biosimilars.

Who should attend?

This conference is intended for a diverse group including:

  • Scientists, clinicians, regulatory, and quality personnel, responsible for the evaluation of safety and efficacy of biosimilars;
  • Parties interested in ongoing efforts on research and development of biosimilars;
  • Program officers from agencies such as FDA, NIH, and CMS and their global counterparts.

Register:

To register to attend this event, visit the event registration page: PDA/FDA Biosimilars Conferencedisclaimer icon

Contact:

Andrea Chamblee at Andrea.chamblee@fda.hhs.gov

Back to Top